A clinical pilot study on the effect of the probiotic Lacticaseibacillus rhamnosus TOM 22.8 strain in women with vaginal dysbiosis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
28 01 2021
Historique:
received: 31 07 2020
accepted: 04 01 2021
entrez: 29 1 2021
pubmed: 30 1 2021
medline: 2 10 2021
Statut: epublish

Résumé

Lactobacilli with probiotic features play an essential role in maintaining a balanced vaginal microbiota and their administration has been suggested for the treatment and prevention of vaginal dysbiosis. The present study was aimed to in vitro and in vivo investigate the probiotic potential of the Lacticaseibacillus rhamnosus TOM 22.8 strain, isolated from the vaginal ecosystem of a healthy woman. For this purpose, safety and functional properties were in depth evaluated. The strain exhibited a broad spectrum of antagonistic activity against vaginal pathogens; adhesion capacity to both the vaginal VK2/E6E7 and the intestinal Caco-2 cells; anti-inflammatory and antioxidant activities, suggesting its promising probiotic features. In addition, an in vivo pilot-study was planned. Based on both clinical and microbiological parameters, the oral or vaginal strain administration, determined a significant pathogens reduction after 10 days of administration and a maintenance of eubiosis up to 30 days after the end of the treatment. Therefore, the L. rhamnosus TOM 22.8 strain can be proposed as valuable oral and/or vaginal treatment for vaginal dysbiosis.

Identifiants

pubmed: 33510271
doi: 10.1038/s41598-021-81931-z
pii: 10.1038/s41598-021-81931-z
pmc: PMC7843994
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2592

Références

Interdiscip Perspect Infect Dis. 2008;2008:256490
pubmed: 19343185
Res Microbiol. 2004 Jun;155(5):376-86
pubmed: 15207870
Food Microbiol. 2015 Sep;50:109-17
pubmed: 25998823
Int J Probiotics Prebiotics. 2008;3(4):219-230
pubmed: 20657710
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4680-7
pubmed: 20534435
Best Pract Res Clin Obstet Gynaecol. 2007 Jun;21(3):355-73
pubmed: 17434799
PLoS One. 2015 Jun 22;10(6):e0131220
pubmed: 26098675
PLoS One. 2012;7(4):e34540
pubmed: 22509319
PLoS Pathog. 2017 May 22;13(5):e1006403
pubmed: 28542528
BJOG. 2020 Jan;127(2):287-299
pubmed: 31299136
Int J Environ Res Public Health. 2019 Oct 12;16(20):
pubmed: 31614736
APMIS. 2005 May;113(5):305-16
pubmed: 16011656
Dermatol Ther. 2019 Jul;32(4):e12970
pubmed: 31112355
Microbes Infect. 2002 Mar;4(3):319-24
pubmed: 11909742
Microbiol Mol Biol Rev. 2008 Dec;72(4):728-64, Table of Contents
pubmed: 19052326
Microb Ecol Health Dis. 2017 Jan 01;28(1):1357417
pubmed: 28959181
Microorganisms. 2019 Aug 12;7(8):
pubmed: 31408976
Sci Rep. 2014 May 30;4:5136
pubmed: 24875844
Sci Rep. 2019 Mar 4;9(1):3355
pubmed: 30833631
Exp Ther Med. 2020 Oct;20(4):3749-3765
pubmed: 32855726
Front Med (Lausanne). 2018 Jun 13;5:181
pubmed: 29951482
Microbiol Mol Biol Rev. 2003 Jun;67(2):277-301, table of contents
pubmed: 12794193
Biotechnol Adv. 2018 Dec;36(8):2060-2076
pubmed: 30266342
J Clin Microbiol. 1991 Feb;29(2):297-301
pubmed: 1706728
Food Chem Toxicol. 2018 Oct;120:277-286
pubmed: 30009890
Int J Immunopathol Pharmacol. 2017 Jun;30(2):163-167
pubmed: 28580872
Sex Transm Infect. 2004 Feb;80(1):8-11
pubmed: 14755028
Front Microbiol. 2018 Jun 15;9:1278
pubmed: 29963028
J Infect Dis. 2001 Mar 1;183 Suppl 1:S77-80
pubmed: 11171021
Ann Ig. 2013 Sep-Oct;25(5):443-56
pubmed: 24048183
J Appl Microbiol. 2001 Nov;91(5):846-52
pubmed: 11722662
Can J Microbiol. 2017 Apr;63(4):269-277
pubmed: 28177795
Eur J Obstet Gynecol Reprod Biol. 2018 Sep;228:232-237
pubmed: 30014929
Food Microbiol. 2014 Apr;38:240-9
pubmed: 24290648
J Appl Microbiol. 2002;93(5):884-93
pubmed: 12392537
Microbes Infect. 2000 Apr;2(5):543-6
pubmed: 10865199
Front Physiol. 2015 Mar 25;6:81
pubmed: 25859220
Am J Med. 1983 Jan;74(1):14-22
pubmed: 6600371
J Clin Microbiol. 1992 Apr;30(4):870-7
pubmed: 1572973
Diagn Microbiol Infect Dis. 2020 Jun;97(2):115024
pubmed: 32253071
Probiotics Antimicrob Proteins. 2019 Sep;11(3):820-829
pubmed: 30141062
Br J Gen Pract. 1999 Nov;49(448):913-8
pubmed: 10818662

Auteurs

Alessandra Pino (A)

Department of Agricultural, Food and Environment, University of Catania, Santa Sofia Street 100, 95123, Catania, Italy.

Agnese Maria Chiara Rapisarda (AMC)

Department of General Surgery and Medical Surgical Specialties, University of Catania, 95123, Catania, Italy.

Salvatore Giovanni Vitale (SG)

Department of General Surgery and Medical Surgical Specialties, University of Catania, 95123, Catania, Italy.

Stefano Cianci (S)

Department of Obstetrics and Gynecology, University of Messina, Messina, Italy.

Cinzia Caggia (C)

Department of Agricultural, Food and Environment, University of Catania, Santa Sofia Street 100, 95123, Catania, Italy.

Cinzia Lucia Randazzo (CL)

Department of Agricultural, Food and Environment, University of Catania, Santa Sofia Street 100, 95123, Catania, Italy. cranda@unict.it.

Antonio Cianci (A)

Department of General Surgery and Medical Surgical Specialties, University of Catania, 95123, Catania, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH